AAAAAA

   
Results: 1-14 |
Results: 14
PHASE-I STUDY OF THE DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) INHIBITOR ENILURACIL (GW776C85) AND ORAL 5-FU WITH CONCOMITANT RADIOTHERAPY (XRT) FOR RECURRENT OR ADVANCED HEAD AND NECK-CANCER (HNC)
Authors: VOKES EE HUMERICKHOUSE R DOLAN E BROCKSTEIN B HARAF D STENSON K KIES M SULZEN L HOUSE L RATAIN MJ
Citation: Ee. Vokes et al., PHASE-I STUDY OF THE DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) INHIBITOR ENILURACIL (GW776C85) AND ORAL 5-FU WITH CONCOMITANT RADIOTHERAPY (XRT) FOR RECURRENT OR ADVANCED HEAD AND NECK-CANCER (HNC), Annals of oncology, 9, 1998, pp. 597-597
CONCOMITANT 5-FU, HYDROXYUREA AND CISPLATIN WITH EXTERNAL-BEAM RADIATION-THERAPY FOR LOCALLY ADVANCED PANCREATIC-CANCER - A PHASE-II STUDY
Authors: CHEN LM HARAF D BRACHMAN DG VOKES EE SCHILSKY RL
Citation: Lm. Chen et al., CONCOMITANT 5-FU, HYDROXYUREA AND CISPLATIN WITH EXTERNAL-BEAM RADIATION-THERAPY FOR LOCALLY ADVANCED PANCREATIC-CANCER - A PHASE-II STUDY, Oncology Reports, 4(5), 1997, pp. 877-881
PERFORMANCE AND QUALITY-OF-LIFE OUTCOME IN PATIENTS COMPLETING CONCOMITANT CHEMORADIOTHERAPY PROTOCOLS FOR HEAD AND NECK-CANCER
Authors: LIST MA MUMBY P HARAF D SISTON A MICK R MACCRACKEN E VOKES E
Citation: Ma. List et al., PERFORMANCE AND QUALITY-OF-LIFE OUTCOME IN PATIENTS COMPLETING CONCOMITANT CHEMORADIOTHERAPY PROTOCOLS FOR HEAD AND NECK-CANCER, Quality of life research, 6(3), 1997, pp. 274-284
INTENSIVE MULTIMODALITY THERAPY CARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA
Authors: MAUER A HARAF D FERGUSON M HOFFMAN P OLAK J DRINKARD L MASTERS G VOKES E
Citation: A. Mauer et al., INTENSIVE MULTIMODALITY THERAPY CARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA, Journal of investigative medicine, 44(7), 1996, pp. 396-396
THE PERFORMANCE STATUS SCALE FOR HEAD AND NECK-CANCER PATIENTS AND THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY HEAD AND NECK SCALE - A STUDY OF UTILITY AND VALIDITY
Authors: LIST MA DANTONIO LL CELLA DF SISTON A MUMBY P HARAF D VOKES E
Citation: Ma. List et al., THE PERFORMANCE STATUS SCALE FOR HEAD AND NECK-CANCER PATIENTS AND THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY HEAD AND NECK SCALE - A STUDY OF UTILITY AND VALIDITY, Cancer, 77(11), 1996, pp. 2294-2301
HYDROXYUREA WITH CONTINUOUS-INFUSION PACLITAXEL, 5-FLUOROURACIL, AND CONCOMITANT RADIOTHERAPY FOR POOR-PROGNOSIS HEAD AND NECK-CANCER
Authors: VOKES EE STUPP R HARAF D MORAN W MALONE D WENIG B SWEENEY P WEICHSELBAUM RR
Citation: Ee. Vokes et al., HYDROXYUREA WITH CONTINUOUS-INFUSION PACLITAXEL, 5-FLUOROURACIL, AND CONCOMITANT RADIOTHERAPY FOR POOR-PROGNOSIS HEAD AND NECK-CANCER, Seminars in oncology, 22(3), 1995, pp. 47-52
SWALLOWING FUNCTION FOLLOWING MULTISPECIALTY ORGAN PRESERVATION TREATMENT OF ADVANCED HEAD AND NECK-CANCER
Authors: KARNELL MP MACCRACKEN E MORAN WJ VOKES E HARAF D PANJE WR
Citation: Mp. Karnell et al., SWALLOWING FUNCTION FOLLOWING MULTISPECIALTY ORGAN PRESERVATION TREATMENT OF ADVANCED HEAD AND NECK-CANCER, Oncology Reports, 1(3), 1994, pp. 597-601
LOCALIZED PROSTATE-CANCER - USE OF SERIAL PROSTATE-SPECIFIC ANTIGEN MEASUREMENTS DURING RADIATION-THERAPY - AN UPDATE
Authors: VIJAYAKUMAR S KARRISON T QUADRI SF CHAN SK HARAF D PANDYA K HOUGHTON A RUBIN S KALOKHE U HALPERN H MULLERRUNKEL R SUTTON H AWAN A WEICHSELBAUM R
Citation: S. Vijayakumar et al., LOCALIZED PROSTATE-CANCER - USE OF SERIAL PROSTATE-SPECIFIC ANTIGEN MEASUREMENTS DURING RADIATION-THERAPY - AN UPDATE, Onkologie, 17(6), 1994, pp. 578-585
A PHASE-I STUDY OF CHEMORADIOTHERAPY WITH CISPLATIN (CDDP) AND NAVELBINE (NVB) FOR ADVANCED MALIGNANCIES OF THE CHEST
Authors: MASTERS G DRINKARD L HOFFMAN P GOLOMB H HARAF D LAW N OLAK J FERGUSON M WATSON S VOKES E
Citation: G. Masters et al., A PHASE-I STUDY OF CHEMORADIOTHERAPY WITH CISPLATIN (CDDP) AND NAVELBINE (NVB) FOR ADVANCED MALIGNANCIES OF THE CHEST, Clinical research, 42(3), 1994, pp. 10000378-10000378
LOCOREGIONALLY ADVANCED PARANASAL SINUS CARCINOMA - FAVORABLE SURVIVAL WITH MULTIMODALITY THERAPY
Authors: ROSEN A VOKES EE SCHER N HARAF D WEICHSELBAUM RR PANJE WR
Citation: A. Rosen et al., LOCOREGIONALLY ADVANCED PARANASAL SINUS CARCINOMA - FAVORABLE SURVIVAL WITH MULTIMODALITY THERAPY, Archives of otolaryngology, head & neck surgery, 119(7), 1993, pp. 743-746
TIME-DOSE ANALYSIS OF LOCAL-CONTROL FOR ADVANCED HEAD AND NECK NEOPLASMS TREATED WITH CONCOMITANT CHEMORADIOTHERAPY ON AN ALTERNATE WEEK SCHEDULE
Authors: WONG W HARAF D VOKES E MICK R WEICHSELBAUM R
Citation: W. Wong et al., TIME-DOSE ANALYSIS OF LOCAL-CONTROL FOR ADVANCED HEAD AND NECK NEOPLASMS TREATED WITH CONCOMITANT CHEMORADIOTHERAPY ON AN ALTERNATE WEEK SCHEDULE, International journal of radiation oncology, biology, physics, 27, 1993, pp. 241-242
LONG-TERM EXPERIENCE WITH CISPLATIN-BASED INDUCTION CHEMOTHERAPY AND CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK-CANCER(HNC)
Authors: STUPP R HARAF D KOZLOFF M MCEVILLY J WEICHSELBAUM R VOKES E
Citation: R. Stupp et al., LONG-TERM EXPERIENCE WITH CISPLATIN-BASED INDUCTION CHEMOTHERAPY AND CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK-CANCER(HNC), Clinical research, 41(3), 1993, pp. 10000647-10000647
A PHASE-I-II TRIAL OF CISPLATIN (CDDP), 5-FLUOROURACIL (5FU), LEUCOVORIN, (PFL), AND NAVELBINE (NVB) IN ADVANCED NON-SMALL-CELL LUNG-CANCER(NSCLC)
Authors: DRINKARD L SAMUELS B HOFFMAN P GOLOMB H BITRAN J FERGUSON M WATSON S HARAF D VOKES E
Citation: L. Drinkard et al., A PHASE-I-II TRIAL OF CISPLATIN (CDDP), 5-FLUOROURACIL (5FU), LEUCOVORIN, (PFL), AND NAVELBINE (NVB) IN ADVANCED NON-SMALL-CELL LUNG-CANCER(NSCLC), Clinical research, 41(3), 1993, pp. 10000704-10000704
P53 MUTATION DOES NOT CORRELATE WITH RADIOSENSITIVITY IN 24 HEAD AND NECK-CANCER CELL-LINES
Authors: BRACHMAN DG BECKETT M GRAVES D HARAF D VOKES E WEICHSELBAUM RR
Citation: Dg. Brachman et al., P53 MUTATION DOES NOT CORRELATE WITH RADIOSENSITIVITY IN 24 HEAD AND NECK-CANCER CELL-LINES, Cancer research, 53(16), 1993, pp. 3667-3669
Risultati: 1-14 |